The research has shown that up to three quarters of patients with cancer may at least supplement their treatment with such therapies, spending as much on CAMS as conventional drugs. This book provides various perspectives on CAMS from patients and CAMS practitioners to conventional doctors who oppose the use of these alternative treatments.